Cite
MLA Citation
TK Kvien et al.. “THU0393 Secukinumab provides sustained reduction in fatigue in patients with ankylosing spondylitis through 3 years: long-term results of two randomised double-blind placebo-controlled phase 3 studies.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 355–356. http://access.bl.uk/ark:/81055/vdc_100135132938.0x000063